CD19 Antibody

CAT: 0223-43-297Size: 0.1 mgDry Ice: NoHazardous: No
CAT#:0223-43-297Size:0.1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
NCBI Gene ID
930
Swiss Prot
P15391
Accession Number
NP_001171569.1, NP_001761.3
Host
Goat
Reactivity
Human
Immunogen
The immunogen for this antibody is: C-ENDSNLGQDQLS
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Other
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration
500 ug/mL
Homology
Expected Species Reactivity based on sequence homology: Cow
Buffer
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Aliquot and store at -20˚ C. Minimize freezing and thawing.
Calculated Molecular Weight
Approx 75kDa
Specificity
This antibody is expected to recognize both reported isoforms (NP_001171569.1; NP_001761.3) .
Applications Notes
Peptide ELISA: Western Blot:
Symbol
CD19
NCBI Official Name
CD19 molecule
NCBI Organism
Homo sapiens
Background Reference 01
Dobbs AK, Bosompem A, Coustan-Smith E, Tyerman G, Saulsbury FT, Conley ME.Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19.
Other Product Names
CD19, CD19 molecule, B4, CVID3, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, differentiation antigen CD19
Tested Applications
ELISA, WB
Protein ID
160332376
Physical Properties
Liquid

Related Products

CatalogName
43-297PCD19 Peptide
91-513CD19 Recombinant Protein
10-674Obexelimab (CD19) - Research Grade Biosimilar
10-676Tafasitamab (CD19) - Research Grade Biosimilar
10-850Loncastuximab (CD19) - Research Grade Biosimilar
10-700Inebilizumab (CD19) - Research Grade Biosimilar
10-128Blinatumomab (CD19/CD3E) - Research Grade Biosimilar
10-780Duvortuxizumab (CD19/CD3E) - Research Grade Biosimilar
10-658Denintuzumab Mafodotin (CD19) - Research Grade Biosimilar
10-655Coltuximab Ravtansine (CD19) - Research Grade Biosimilar

Alternative Products

CatalogName
MBS8584187-01CD19 Antibody
C2269-33CD19 (Protein Cd19, CD19 Molecule)

Popular Products